Christopher Benecchi
CIK 1881403 · Chief Operating Officer · last filed 2025-07-31
Christopher Benecchi is a Chief Operating Officer who has filed 12 SEC Form 4 insider transactions across 1 company since 2021. The most recent filing, for SAGE, was dated Jul 31, 2025.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
1
12
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Sage Therapeutics, Inc. (SAGE) Delisted | Chief Operating Officer | 0 | $8.68 | $0 | $0 | 12 | 2025-07-31 |
Recent Filings
12 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-07-31 | Sage Therapeutics, Inc. (SAGE) Delisted | Disp (D) | −64,428 | $0 | EDGAR |
| 2025-04-11 | Sage Therapeutics, Inc. (SAGE) Delisted | Mixed | +4,513 | -$10.0K | EDGAR |
| 2025-02-14 | Sage Therapeutics, Inc. (SAGE) Delisted | Tax (F) | −822 | -$5.9K | EDGAR |
| 2025-01-21 | Sage Therapeutics, Inc. (SAGE) Delisted | Grant (A) | +20,000 | $0 | EDGAR |
| 2024-11-14 | Sage Therapeutics, Inc. (SAGE) Delisted | Grant (A) | +6,250 | $0 | EDGAR |
| 2024-08-07 | Sage Therapeutics, Inc. (SAGE) Delisted | Mixed | +11,445 | -$42.6K | EDGAR |
| 2024-02-15 | Sage Therapeutics, Inc. (SAGE) Delisted | Grant (A) | +13,500 | $0 | EDGAR |
| 2023-02-15 | Sage Therapeutics, Inc. (SAGE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-02-07 | Sage Therapeutics, Inc. (SAGE) Delisted | Mixed | +4,631 | -$93.6K | EDGAR |
| 2022-06-21 | Sage Therapeutics, Inc. (SAGE) Delisted | Grant (A) | — | $0 | EDGAR |